Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study

10.1002/dad2.12095

Saved in:

Bibliographic Details
Main Authors:	Wang, H.-F., Shen, X.-N., Li, J.-Q., Suckling, J., Tan, C.-C., Wang, Y.-J., Feng, L., Zhang, C., Tan, L., Dong, Q., Touchon, J., Gauthier, S., Yu, J.-T.
Other Authors:	DEPT OF PSYCHOLOGICAL MEDICINE
Format:	Article
Published:	John Wiley and Sons Inc 2021
Subjects:	Alzheimer's disease amyloid beta biomarkers clinical tau
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/196815
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Biomarkers of mild cognitive impairment and Alzheimer's disease
by: Tang, B.L., et al.
Published: (2011)

Truncated Tau caused by intron retention is enriched in Alzheimer’s disease cortex and exhibits altered biochemical properties
by: Ngian, ZK, et al.
Published: (2023)

Neuropathological mechanisms associated with pesticides in Alzheimer's disease
by: Tang, B.L.
Published: (2021)

The roles of amyloid precursor protein (APP) in neurogenesis, implications to pathogenesis and therapy of alzheimer Disease (AD)
by: Zhou, Z.-D., et al.
Published: (2014)

The roles of amyloid precursor protein (APP) in neurogenesis, implications to pathogenesis and therapy of alzheimer Disease (AD)
by: Zhou Z.-D., et al.
Published: (2018)

Regulated trafficking of APP by SORLA in Alzheimer's disease
by: Lao, Angelyn R., et al.
Published: (2012)

Microglia and CD206⁺ border-associated mouse macrophages maintain their embryonic origin during Alzheimer's disease
by: Wu, Xiaoting, et al.
Published: (2022)

Regulated trafficking of APP by SORLA in Alzheimer’s disease
by: Lao, Angelyn R.
Published: (2012)

ASSESSING POTENTIAL INFLAMMATORY BIOMARKERS AND ANTI-NEUROINFLAMMATORY THERAPIES FOR ALZHEIMER'S DISEASE
by: ZHU YANAN
Published: (2018)

Multi-compartmental modeling of APP processing influenced by SORLA in Alzheimer’s disease
by: Lao, Angelyn R.
Published: (2012)

Multi-compartmental modeling of SORLA’s influence on amyloidogenic processing in Alzheimer’s disease
by: Lao, Angelyn R., et al.
Published: (2012)

Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
by: Schmidt, Vanessa, et al.
Published: (2011)

Multi-compartmental modeling of APP processing influenced by SORLA in Alzheimer’s disease
by: Lao, Angelyn R., et al.
Published: (2012)

Mathematical modeling of APP processing influenced by SORLA in Alzheimer's disease: Two pilot models
by: Lao, Angelyn R.
Published: (2010)

Mathematical modelling of APP processing influenced by SORLA in Alzheimer's Disease: When one pathway is not enough
by: Lao, Angelyn R.
Published: (2011)

Mathematical modeling of APP processing influenced by SORLA in Alzheimer's disease: When one pathway is not enough
by: Lao, Angelyn R.
Published: (2011)

A systems biology approach to understand amyloidogenic processing in Alzheimer's disease: Making sense of data and providing meaning to models
by: Lao, Angelyn R.
Published: (2014)

Peripheral biomarkers for early detection of Alzheimer's and Parkinson's diseases
by: Htike, Thein Than, et al.
Published: (2020)

Stochastic process algebra modeling of APP processing influenced by SORLA in Alzheimer's disease
by: Lao, Angelyn R.
Published: (2014)

Predicting energetically favorable residue interactions between LL-37 and familial alzheimer's disease mutants of Aβ42 using molecular dynamics simulations
by: Miranda, Martin Carlos Y.
Published: (2024)

Stability analysis of the ODE model representation of amyloidogenic processing in Alzheimer's disease in the presence of SORLA
by: Alcantara, Jan Harold Mercado, et al.
Published: (2016)

The Role of Hydrogen Sulfide in the Central Nervous System: Implications in the Treatment of Alzheimer's Disease
by: BHUSHAN VIJAY NAGPURE
Published: (2015)

THERAPEUTIC POTENTIAL OF CHIMERIC AMYLOID-BETA PRECURSOR PROTEIN INTRACELLULAR DOMAIN MUTANT IN ALZHEIMER'S DISEASE
by: PAWAN KUMAR
Published: (2020)

A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer's disease
by: Teo, E., et al.
Published: (2021)

Production and characterization of chimeric transthyretin scavenger for amyloidosis and alzheimer's disease related proteins : Research final report
by: Porntip Prapunpoj, et al.
Published: (2012)

Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease
by: Chong, JR, et al.
Published: (2023)

Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease
by: Fairley, Lauren H., et al.
Published: (2021)

Absence of A673T amyloid-β precursor protein variant in alzheimer's disease and other neurological diseases
by: Ting, S.K.S., et al.
Published: (2014)

Effects of γ-secretase cleavage-region mutations on APP processing and Aβ formation: Interpretation with sequential cleavage and α-helical model
by: Tan, J., et al.
Published: (2014)

Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances
by: Chong, Joyce R, et al.
Published: (2023)

Microglial in neurodegenerative disorders: Emphasis on Alzheimer's disease
by: McRae, A., et al.
Published: (2012)

AMYLOID PRECURSOR PROTEIN SIGNALING IN PHYSIOLOGY AND ALZHEIMER?S DISEASE
by: JOANITA BINTE JASMEN
Published: (2016)

Cytotoxicity os transthyretin amyloid to peripheral tissue and use of the peripheral tissue for cell based screening of the amyloid inhibitors
by: Porntip Prapunpoj
Published: (2015)

Upregulated blood miR-150-5p in alzheimer's disease dementia is associated with cognition, cerebrospinal fluid amyloid-β, and cerebral atrophy
by: Chia, Sook Yoong, et al.
Published: (2023)

Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP
by: Nizetic, Dean, et al.
Published: (2016)

Metabolomic changes in autopsy-confirmed Alzheimer's disease
by: Kaddurah-Daouk, R., et al.
Published: (2014)

NOVEL OXIDATIVE STRESS-ASSOCIATED BIOMARKERS OF ALZHEIMER’S DISEASE AND VASCULAR COGNITIVE IMPAIRMENT
by: WU LIUYUN
Published: (2024)

Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly
by: Zhang, L., et al.
Published: (2021)

Catching tau in the act
by: Wong, B.-S., et al.
Published: (2013)

Network dysfunction in Alzheimer's disease and frontotemporal dementia: Implications for psychiatry
by: Zhou, J., et al.
Published: (2016)